The daily business briefing: April 6, 2016

Pfizer scraps $160 billion Allergan merger, PayPal ends North Carolina expansion over anti-LGBT law, and more

Pfizer drops bid for Allergan
(Image credit: Spencer Platt/Getty Images)

1. Pfizer kills Allergan merger after U.S. tightens loophole

Pfizer on Wednesday confirmed that it had scrapped its $160 billion deal to take over smaller Dublin-based drug maker Allergan, putting an end to what would have been the biggest corporate inversion ever. The decision came a day after the Treasury Department unveiled new rules designed to curb such mergers, which corporations use to reduce their tax burdens by merging with foreign companies and shifting their home base overseas. The deal's demise marked a victory for President Obama, who on Tuesday called on Congress to close the corporate inversion loophole completely.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.